Skip to main content Skip to search Skip to main navigation

Selection and procurement of cleanroom construction components

An excerpt from the new e-book A Pharma Guide to Planning and Constructing Cleanrooms

5 min. reading time | by André Deister, Sabine Mendel
Published in LOGFILE 03/2020

Selection and procurement

Which factors influence component selection?

In selecting the construction components, important factors to consider are

  • the process and product-specific requirements to be derived from the manufacturing processes,
  • the resulting specified cleanroom classes,
  • the desired flexibility (single or multi-purpose) and
  • the intended detergents and disinfectants.

National and international guidelines also require risk assessments when designing plants and when determining the scope of qualification/validation.

This gives rise to special hygienic and cleanroom requirements for components. Different requirements also result from the intended type of usage. Administration, research and laboratory buildings have different requirements than production rooms. The requirements for production areas and clean rooms used for pharmaceutical purposes have a higher standard than other buildings, even if these components are not in direct contact with pharmaceutical products. An example of a risk-based assessment of surfaces in connection with their proximity to the product and cleanability is discussed in chapter 1.9 Example of a risk assessment for surfaces.

 

How do the requirements put on rooms for pharmaceutical use differ from the requirements put on other building types?

Special operational requirements can also include measures for ergonomic workstation design that is well accepted by the operating personnel (e.g. colour schemes for surfaces, etc.)

The need to provide greater heights and thus increased space for the room-air installations above the cleanroom ceiling and their accessibility for maintenance is also an essential factor in the shell construction.

In the following chapters, the design options for pharmaceutical cleanroom construction of GMP classes A–D are described. The requirements for non-sterile production are not as high. Solutions for non-sterile production and also temperature-controlled areas (cooling rooms, incubation rooms, etc.) are not explicitly dealt with here, but can be applied analogously.

  • Higher sealing requirements for external façades. A maximum specific façade leakage of < 0.3 m³ x h-1 × m-2 at a static pressure of 500 Pa to minimize the rate of incursion of particles from outside [1]
  • Higher seal effectiveness requirements for the surrounding surfaces of a cleanroom (increased seal effectiveness can also lead to problems regarding control of room pressures – see also 3.I.12.4 Room Pressure Differential Control)
  • Smooth surfaces free of pores, free of cracks and uncontrolled dead spaces which are not easy to access for cleaning
  • Not susceptible to accumulate or release particles or release gasses from component materials (“molecular contamination”)
  • No materials which could serve as breeding grounds for microorganisms
  • Resistant to intended detergents and disinfectants and cleaning procedures
  • In certain cases, properties impacting electrostatic charges are a criterion (e.g. when processing powders, during media transfer into plastic tubes)
  • Other installations (pipes, air ducts, electrical installations) should be installed in a manner conducive to cleaning – cladding all the way up to ceiling or assurance of a minimum distance according to the cleaning procedures
  • Simple and properly sealed incorporation of various installations such as airflow vents (inlet, exhaust, cross flows), lighting installations, smoke detectors, sprinklers, etc.
     

[1] From Report No. 6, Particle transport through leaking façades (Partikeltransport durch undichte Fassaden), Dohm Pharmaceutical Engineering, Dr.-Ing. Wolf Ziemer, DI(FH) Mike Urack, May 2009, www.dphe.de


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

André Deister
André Deister

You may also be interested in the following articles:

Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
News: Europe

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT